00874

Guangzhou Baiyunshan Pharmaceuti…

17.02

-0.16-0.93%

Closed16:08 05/13 HKT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE17.180/17.180

TODAY RANGE17.020-17.300

VOL806.00K

MARKET CAP27.67B

52 WEEK RANGE15.760-24.200

AVG VOL (3M)1.46M

% TURNOVER0.05%

TURNOVER13.86M

P/E (TTM)9.462

% RANGE1.63%

EPS(TTM)1.799

P/E(FORWARD)8.180

P/B0.677

BVPS25.141

DIVIDEND0.854

P/S0.308

BETA--

DIV YIELD5.02%

FREE FLOAT MKT CAP3.74B

SHARES OUTSTANDING1.63B

NEXT EARNINGS08/30-09/06

FREE FLOAT219.90M

LOT SIZE2000

EX-DIV DATE10/15/2024

News

Press Releases

Financial Reports

Profile

Simply Wall St·04/28 23:21
Returns On Capital At Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Paint A Concerning Picture
Simply Wall St·04/07 02:54
Calculating The Intrinsic Value Of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:874)
Simply Wall St·03/14 23:07
Guangzhou Baiyunshan Pharmaceutical Holdings Full Year 2024 Earnings: Misses Expectations
Simply Wall St·03/03 23:49
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's (HKG:874) Low P/E No Reason For Excitement
Simply Wall St·02/04 00:31
Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Has A Pretty Healthy Balance Sheet
Simply Wall St·01/07 05:23
There Are Reasons To Feel Uneasy About Guangzhou Baiyunshan Pharmaceutical Holdings' (HKG:874) Returns On Capital
Simply Wall St·12/17/2024 02:19
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:874) stock most popular amongst private companies who own 46%, while individual investors hold 36%
Simply Wall St·11/22/2024 23:26
Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) investors are sitting on a loss of 9.5% if they invested five years ago
Reuters·11/14/2024 02:39
BUZZ-Tencent rises most in 2 weeks after strong Q3 results
Simply Wall St·11/01/2024 22:27
Guangzhou Baiyunshan Pharmaceutical Holdings' (HKG:874) Shareholders Have More To Worry About Than Only Soft Earnings
Simply Wall St·10/29/2024 22:05
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Recorded A 7.9% Miss On Revenue: Analysts Are Revisiting Their Models
Simply Wall St·10/27/2024 00:08
Guangzhou Baiyunshan Pharmaceutical Holdings Third Quarter 2024 Earnings: EPS: CN¥0.38 (vs CN¥0.60 in 3Q 2023)
Simply Wall St·10/17/2024 00:22
Is Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) A Risky Investment?
Simply Wall St·09/25/2024 23:05
Here's What's Concerning About Guangzhou Baiyunshan Pharmaceutical Holdings' (HKG:874) Returns On Capital
Simply Wall St·09/04/2024 22:57
Earnings Report: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Missed Revenue Estimates By 8.1%

Same Industry

Name/Symbol

Change%

Price

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

-0.93%

17.020

Amgen

04332

Wuxi Apptec

02359

-0.64%

62.400

China Conch Venture Holdings

00586

-1.53%

7.700

Asymchem Laboratories (Tianjin)

06821

+1.40%

54.450

Sinopharm Group

01099

-1.07%

18.420

Livzon Pharmaceutical Group

01513

-0.19%

26.150

Shanghai Pharmaceuticals Holding

02607

-1.78%

11.020

Shanghai Fosun Pharmaceutical (Group)

02196

-1.14%

13.920

China Medical System Holdings

00867

-0.97%

8.160

SciClone Pharmaceuticals (Holdings)

06600

0.00%

18.720

China Isotope & Radiation

01763

-0.34%

11.620

Wuxi Biologics (Cayman)

02269

-0.43%

23.150

China Shineway Pharmaceutical Group

02877

-1.11%

7.140

The United Laboratories International Holdings

03933

+2.03%

13.040

Consun Pharmaceutical Group

01681

+0.21%

9.440

3SBio

01530

+2.50%

11.500

Shandong Xinhua Pharmaceutical

00719

-0.35%

5.690

Beijing Tong Ren Tang Chinese Medicine

03613

-1.28%

8.480

China Resources Pharmaceutical Group

03320

-1.20%

4.950

CSPC Pharmaceutical Group

01093

+0.55%

5.530

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.